News | Pacemakers | November 13, 2019

Wireless and Leadless Pacemaker Being Developed by Texas Heart Institute With Federal Grant

Co-principal investigator professor Aydin Babakhani at the UCLA Integrated Sensor Laboratory holds an earlier version of the prototype leadless, wireless amnd batteryless pacemaker. Photo Credit: Cody Duty, Texas Medical Center.

Co-principal investigator professor Aydin Babakhani at the UCLA Integrated Sensor Laboratory holds an earlier version of the prototype leadless, wireless and battery-less pacemaker. Photo Credit: Cody Duty, Texas Medical Center.

Mehdi Razavi, M.D., sharing the history of the pacemaker on display in the Texas Heart Institute Wallace Wilson Museum in Houston.

Mehdi Razavi, M.D., sharing the history of the pacemaker on display in the Texas Heart Institute Wallace Wilson Museum in Houston.

November 13, 2019 — Texas Heart Institute (THI) was awarded a prestigious four-year, $2.39 million grant from the National Institutes of Health (NIH) to explore further the development of a novel pacemaker system that is both leadless and wirelessly powered. 

Mehdi Razavi, M.D., director of electrophysiology clinical research and innovations at THI, co-principal investigator professor Aydin Babakhani at UCLA Integrated Sensors Laboratory (ISL), and co-principal investigator Behnaam Aazhang, Ph.D., J.S. Abercrombie Professor, electrical and computer engineering, Rice University, will lead the device development and research studies. The new pacemakers allow simultaneous pacing and sensing from multiple sites in the heart to help reduce the complications associated with the traditional pacemakers in use today.

“Current wireless pacemakers can be effective for patients with certain types of atrial fibrillation and in patients with a medical condition or anatomy that blocks access to the vessels where traditional pacemaker leads are attached," Razavi, said. "However, if the patient needs dual-chamber pacing, we are forced to use a traditional pacemaker with leads. Pacemaker wires called leads are prone to fracturing, dislodging and migrating away from the original location. Our technology could overcome this problem and make wireless, leadless, battery-less pacemakers available to these patients.” 

The pacing and sensing devices will be based on silicon-based integrated microchips that were built in Babakhani’s laboratory at UCLA. Post-doctoral scholar Hongming Lyu and Ph.D. students Hamed Rahmani and Yuxiang Lyu of Babakhani’s laboratory at UCLA designed the earlier version of the device. Babakhani’s laboratory has pushed the limits of miniaturization so that an entire pacemaker can fit inside a vein. The miniaturized pacemaker eliminates the need for bulky batteries as it receives energy and commands wirelessly through electromagnetic waves from an external controller. 

“One of the major challenges of this technology is maintaining the efficiency of wireless power transfer as the device becomes very small and the antenna becomes inefficient," explained Babakhani. "We have addressed this issue by significantly lowering the power consumption of the electronics used in the pacemaker, integrating all the elements on a single chip, and designing antennas that resonate strongly with the input circuitry of the pacing chips."

A Short History of Pacemakers 

Mehdi Razavi, M.D., sharing the history of the pacemaker on display in the Texas Heart Institute Wallace Wilson Museum in Houston.Pacemakers are used to treat slow heart rates (bradycardia). An American physiologist built the first device referred to as an "artificial pacemaker” in 1932. Powered by a spring-wound, hand-cranked motor, the device was dismissed as nothing more than a gadget and was met with opposition at a time when using technology to alter the natural course of life was highly controversial. Pacemaker advances exploded in the late 1950s and early 1960s with several landmark firsts, including pacemakers that were battery-operated and wearable, totally implantable and self-contained. New battery technology in the 1970s dramatically improved the lifespan of the pacemaker.

After decades of steady pacemaker improvements since the 1970s, a new era of explosive growth for the pacemaker could dramatically improve outcomes and quality of life for millions of people suffering from heart rhythm disorders.

Development of Leadless, Wireless Pacemakers

The Abbott Micra leadless, single chamber pacemaker.New leadless systems are now available, such as the Medtronic Micra, that can provide pacing to one chamber of the heart. However, pacing therapy is typically delivered to multiple chambers of the heart in a synchronized manner, and the bulky size and shape of the new leadless pacemakers do not allow for multi-chamber pacing. Miniature, battery-less devices are being tested in clinical trials, but these devices can only deliver effective therapy in combination with another pacemaker.

Razavi and the team overcome all of these challenges with their wireless, leadless, battery-less pacemaker design.

The pacemaker they are developing also will learn from the data it generates, identify patterns and make adjustments to enable constant optimal patient-specific therapy, according to THI research engineers Allison Post, Ph.D., and Mathews John.

“Our pacemaker is a diagnostic and treatment-delivering device with the ability to constantly read the heart’s electrical needs and self-correct or continuously adjust and recalibrate to deliver a unique pacing treatment, in real time, for each individual,” added Razavi.

 

Receiving Funding to Develop New Cardiovascular Technologies

Beginning with the first artificial heart implant by Dr. Cooley in 1969, THI has addressed significant research gaps and secured critical funding from the National Heart, Lung and Blood Institute (NHLBI) and other government and non-government sources. The NHLBI has been a substantial source of support for THI, stimulating discoveries and enabling the translation of these discoveries into clinical practice.

“THI has a long track record of receiving funding awards from the NIH that have resulted in significant device development and led to productive partnerships with industry,” according to Emerson Perin, M.D., Ph.D., Texas Heart Institute’s medical director.

“Arrhythmias can be devastating and difficult to manage in patients with multiple comorbidities and complicated cardiovascular conditions such as heart failure. Dr. Razavi’s pacemaker is highly innovative, and this transformational funding from the NIH underscores the importance and relevance of his work,” added James T. Willerson, M.D., FACC, Texas Heart Institute president emeritus.

Razavi will oversee the device development and all preclinical studies. Babakhani will oversee the development of the pacing and sensing nodes. Aazhang will supervise the development of the data-driven algorithm, and Joseph R Cavallaro, Ph.D., professor of electrical and computer engineering and director of the Center for Multimedia Communication, and Yingyan Lin, Ph.D., assistant professor, will each contribute to the design of the external controller that processes the signals.

Research reported in this publication is supported by the NHLBI under Award Number 1R01HL144683-01A1. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

For more information: www.texasheart.org

 

Related Pacemaker Content:

New Pacemaker Technologies

CHLA/USC Team Designs Novel Micropacemaker

Safety, Performance of the World's Smallest Pacemaker Reinforced in Real-world Patients

VIDEO: Current State of Leadless Pacemaker Technology — Interview with Vivek Reddy, M.D.

Novel Mechanical Sensor in Medtronic Micra Transcatheter Pacing System Detects Atrial Contractions, Restores AV Synchrony

FDA Warns of Premature Battery Depletion in Some Medtronic Pacemakers

Artificial Intelligence Can Improve Emergency X-ray Identification of Pacemakers

VIDEO: Use of an Antibacterial Envelope to Reduce Infections for Pacemakers, ICDs

New Approaches to EP Lead Management

VIDEO: How to Implant the Micra Leadless Pacemaker

Related Content

Earlier this year, Medtronic began a worldwide pivotal study evaluating its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system to treat dangerously fast heart rhythms. The EV ICD system is designed to deliver lifesaving defibrillation and pacing therapy via a device the same size as traditional, transvenous ICDs, but with a lead (thin wire) placed outside the heart and veins. The future of CRM device technology.

Earlier this year, Medtronic began a worldwide pivotal study evaluating its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system to treat dangerously fast heart rhythms. The EV ICD system is designed to deliver lifesaving defibrillation and pacing therapy via a device the same size as traditional, transvenous ICDs, but with a lead (thin wire) placed outside the heart and veins.

Feature | EP Lab | November 11, 2019 | Hrishikesh Kadam
Cardiac rhythm management (CRM) devices in use today are evolving to raise the bar beyond monitoring and managing car
A comparison between the EPstar 2F and 6F catheters from Baylis. Electrophysiology catheters. EP lab

A comparison between the EPstar 2F and 6F catheters from Baylis.

News | EP Lab | October 31, 2019
October 31, 2019 — Baylis Medical announced the first North American use of its EPstar Fixed...
New Study Shows Chronic Epilepsy Associated With Marker of Cardiac Electrical Instability
News | EP Lab | October 24, 2019
LivaNova PLC announced the publication of a new study in Neurology, which suggests that chronic epilepsy may be...
Lenox Hill Hospital Opens New Heart Rhythm Center
News | EP Lab | August 27, 2019
Lenox Hill Hospital (New York, N.Y.) has established a brand new Heart Rhythm Center dedicated to the treatment of...
Damaged Hearts Rewired With Nanotube Fibers

Researchers at Texas Heart Institute and Rice University have confirmed that flexible, conductive fibers made of carbon nanotubes can bridge damaged tissue to deliver electrical signals and keep hearts beating despite congestive heart failure or dilated cardiomyopathy or after a heart attack. Image courtesy of Texas Heart Institute.

News | EP Lab | August 15, 2019
Thin, flexible fibers made of carbon nanotubes have now proven able to bridge damaged heart tissues and deliver the...
Cardiac Device Complications Vary Widely Among Hospitals
News | EP Lab | July 31, 2019
The chances of patients experiencing complications after having a cardiac device implanted vary according to where they...
A new infection risk scoring system has been developed based on data from the large PADIT Trial.[1] The new scoring system was presented as a follow up to that study during a late-breaking session at Heart Rhythm 2019, the Heart Rhythm Society's 40th Annual Scientific Sessions.

Figure 1: The PADIT infection risk score ranging from 0 to 14 points classified patients into three risk groups, low (0-4), intermediate (5-6) and high (≥7). The risk groups had rates of hospitalization for infection of 0.51%, 1.42% and 3.41%, respectively 

News | EP Lab | May 15, 2019
May 15, 2019 — A new infection risk scoring system has been developed based on data from the large PADIT Trial.[1] Th
Studies Find Race and Gender Disparities in Implantable Heart Devices
News | EP Lab | May 15, 2019
May 15, 2019 - Three new studies show that patients who are medically indicated for implantable heart devices, includ
Overlay Init